1. Home
  2. CADL vs OXLC Comparison

CADL vs OXLC Comparison

Compare CADL & OXLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$4.99

Market Cap

455.8M

Sector

Health Care

ML Signal

N/A

Logo Oxford Lane Capital Corp.

OXLC

Oxford Lane Capital Corp.

N/A

Current Price

$4.96

Market Cap

498.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
OXLC
Founded
1999
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
455.8M
498.0M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
CADL
OXLC
Price
$4.99
$4.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
1
Target Price
★ $17.67
$6.00
AVG Volume (30 Days)
1.4M
★ 2.3M
Earning Date
11-12-2026
11-01-2023
Dividend Yield
N/A
★ 18.86%
EPS Growth
★ 58.62
N/A
EPS
N/A
★ N/A
Revenue
★ $125,000.00
N/A
Revenue This Year
N/A
$136.15
Revenue Next Year
N/A
$5.51
P/E Ratio
★ N/A
$7.72
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$4.62
52 Week High
$14.00
$15.39

Technical Indicators

Market Signals
Indicator
CADL
OXLC
Relative Strength Index (RSI) 25.65 20.02
Support Level $4.62 $4.62
Resistance Level $5.51 $10.10
Average True Range (ATR) 0.70 0.26
MACD -0.33 0.04
Stochastic Oscillator 1.62 15.65

Price Performance

Historical Comparison
CADL
OXLC

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About OXLC Oxford Lane Capital Corp.

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize portfolio's risk adjusted total return, and currently seek to achieve investment objective by investing in structured finance investments, specifically the equity and junior debt tranches of CLO vehicles, which are collateralized by a diverse portfolio of senior secured loans made to companies whose debt is unrated or is rated below investment grade (the Senior Loans) and, to a limited. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

Share on Social Networks: